DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Spirendolol
Spirendolol
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
Customs Tariff - Schedule
Tetrapeptide Renin Inhibitors Having a Novel C-Terminal Amino Acid
Ovid MEDLINE(R)
The Interrelation of Physicochemical Parameters and Topological Descriptors for a Series of Â-Blocking Agents
Renin Inhibitory Peptides Containing Suleptanic Acid Or Derivatives Thereof
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Self-Measured Compared to Office
Multimedia Appendix 1. Search Strategy Developed for Medline Via Ovid to Identify Existing Systematics Review. Concept 1: BP
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
WO 2007/061529 Al
Stembook 2018.Pdf
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
The Pharmacological Treatment of Arterial Hypertension in Frail, Older Patients a Systematic Review
Synthesis of Optically Active Aryloxypropanolamines and Arylethanolamines
Customs Tariff - Schedule Xxi - 1
Tarif Intégré Des Communautés Européennes (TARIC)
(12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
Mechanisms of Actions of Drugs Which Alter Intraocular Pressure Acknowl Edcrements
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
(12) United States Patent (10) Patent No.: US 8,802,850 B2 Rao Et Al
Official Journal ISSN 0378-6978 L97 of the European Communities Volume 45
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Identification and Characterization of Antidiabetic And
E036128.Draft-Revisions.Pdf
Schedule Clxxiii - European Union
Beta-Blockers for Hypertension (Review)
Ep 0312283 A